Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Before testing the combined effect of APG and TRAIL therapy, we first evaluated the cytotoxicity of TRAIL monotherapy in two NSCLC cell lines, A549 and H1299, and a normal cell line HEK293, by means of MTT assay. Our data showed that, at the concentration of 60?ng/mL or lower, TRAIL showed no significant antitumor effect on A549 and H1299 cells, indicating that both NSCLC cell lines had low sensitivity or were resistant to TRAIL monotherapy (Fig. 1b,c).
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
